To choose the right capillary positive control, I first match the control to the complete testing system: sample type, capillary collection method, assay chemistry, instrument, intended use, and quality requirements. A suitable control should produce a predictable positive response without creating handling behavior that is materially different from the intended capillary specimen. I also verify its stability, reconstitution or dispensing procedure, packaging, documentation, and supplier support before making a purchasing decision.
Please visit our website for more information on this topic.
For IVD and POCT projects, the lowest unit price is rarely the only important factor. The control must support method verification, operator training, lot release, troubleshooting, and ongoing quality monitoring. In the sections below, I explain a practical selection process that I use to compare capillary positive controls and identify the most appropriate supply solution.
I begin by identifying why the positive control is required. A control used during assay development may need a broader concentration range and more frequent technical discussion, while a control used for routine POCT quality monitoring may need a simple, repeatable workflow for non-specialist operators. These different objectives can lead to different requirements for matrix composition, format, concentration, packaging, and instructions for use.
I also define whether the control is intended to represent whole blood, plasma, serum, a swab extract, or another specimen-related condition. Capillary blood collection can involve small volumes, variable hematocrit, skin-contact risks, and transfer steps that are not always reproduced by a conventional liquid control. The closer the control is to the intended specimen behavior, the more useful it may be for assessing the practical performance of the complete test process.
Matrix selection is one of the most important decisions because the matrix can influence viscosity, flow, absorption, drying, extraction, and signal development. A control that produces the correct analytical signal but behaves very differently during capillary application may not adequately challenge the operator procedure. I therefore compare not only the target response but also the physical handling characteristics required by the test.
Potential formats may include liquid, dried, stabilized, or reconstitutable materials, depending on the assay and supply design. Liquid controls can simplify preparation, while dried or stabilized formats may be considered when transport or storage conditions make liquid handling less convenient. I do not assume that one format is universally better; I ask the supplier to explain the intended storage, preparation, and use conditions for the specific product.
The control should be evaluated for compatibility with the device materials, extraction buffer, collection tube, transfer tool, and detection system. Relevant characteristics may include viscosity, particulate content, color, surface tension, and the ability to mix consistently. These characteristics should be discussed with the supplier because a control’s practical suitability depends on the complete system rather than on the control name alone.
For concentration, I specify the required positive level and acceptance range instead of simply requesting a “strong positive.” In some applications, a high-level control is useful for confirming reagent or instrument function, while a low-positive control may be more informative for evaluating sensitivity near the decision point. The appropriate level should be established from the assay’s performance objectives and confirmed during verification.
Stability must cover the real supply chain and operating environment. I review the proposed storage temperature, transport conditions, in-use period, container closure, and any freeze-thaw limitations. If a POCT product may be used outside a controlled laboratory, I also ask whether the supplier can provide information relevant to room-temperature exposure and short-term temperature excursions.
As a practical evaluation plan, I may compare performance after storage at 2–8°C, at an intended room-temperature condition such as 20–25°C, and at a higher stress condition such as 37°C. These temperatures are evaluation points, not assumed product specifications; the supplier must confirm which conditions are supported by actual product data. I also define the observation period in days or weeks based on the project schedule rather than accepting an unspecified “stable” statement.
I look for a clear description of the test method, acceptance criteria, tested lots, storage conditions, and time points. If the supplier cannot provide all details, I record the limitation and determine whether additional verification is necessary. A certificate of analysis, product specification, or stability summary can be useful, but each document should be reviewed for relevance to the exact control format and lot supplied.
Link to Zholion
A positive control is only useful when operators can use it consistently. I map every step from opening the package to final result interpretation, including equilibration, mixing, sample transfer, application, incubation, and disposal. If the procedure requires a small volume, I pay particular attention to container design and dispensing accuracy because minor handling differences can affect the final result.
I recommend documenting the intended volume in microliters, the waiting time in minutes, and the allowable storage temperature in degrees Celsius. For example, a draft protocol may specify a 5 µL application, a 15-minute result-reading window, and storage at 2–8°C, but these values should come from the assay procedure or supplier instructions rather than being assumed. Clear, verified instructions reduce operator variation and make training easier.
For instrument-read tests, I confirm whether the control generates an appropriate signal for the optical, electrical, thermal, or molecular detection method. For visually interpreted tests, I assess whether the result can be distinguished using the intended reading conditions and acceptance criteria. Where the control is used with more than one device configuration, each configuration should be assessed separately because reagent lots, membranes, software, or extraction conditions may differ.
Supplier evaluation should include more than a product data sheet. I request the product description, intended use, handling instructions, storage conditions, lot identification approach, packaging information, and available quality documents. I also confirm whether the supplier can support technical questions during method development and whether changes to the control composition or packaging will be communicated through an appropriate change-control process.
Customization may be important when a standard control does not match the required matrix, target level, volume, container, or labeling format. With Zholion, I can discuss the technical requirements for a capillary positive control and clarify whether the requested configuration is feasible for the intended IVD or POCT workflow. Any proposed customization should be reviewed through samples, documented acceptance criteria, and customer-side verification before routine purchase.
One common mistake is choosing a control only because it gives a positive signal in a laboratory demonstration. This can overlook capillary collection behavior, operator technique, extraction efficiency, or device-specific interference. I avoid this by testing the control through the same or a closely representative workflow used for the intended specimen.
Another mistake is treating a generic positive material as automatically suitable for a regulated IVD application. A generic material may be useful for early feasibility work, but the final choice should be supported by application-specific verification and appropriate documentation. I also avoid assuming that a longer stated shelf life, lower price, or larger package is better without understanding the storage burden, consumption rate, and risk of waste.
I normally score candidate controls against the factors that matter most to the project: matrix match, target level, analytical response, workflow compatibility, stability, documentation, customization, supply continuity, and total cost. I assign higher importance to factors that directly affect patient-testing risk or validation effort. This approach makes supplier comparisons more transparent and helps technical, quality, and purchasing teams use the same decision criteria.
Before placing a larger order, I request an evaluation sample when available and define the acceptance criteria in advance. I may compare at least three production lots or sample lots when lot-to-lot consistency is critical, but the appropriate number depends on the validation plan and risk assessment. Results should be recorded with the device version, reagent lot, operator, storage condition, date, and observed outcome.
The best capillary positive control is the one that matches the intended specimen behavior, assay target, concentration requirement, device workflow, storage environment, and quality documentation needs. I do not select it from the product name alone; I confirm how it is prepared, applied, detected, stored, and supported throughout the project. This method helps me distinguish a technically convenient control from one that genuinely supports IVD or POCT verification.
My recommended next step is to prepare a short technical specification covering matrix, target, positive level, application volume, temperature range, use period, packaging, documents, MOQ, and lead time. Share that specification with Zholion for a feasibility review, sample discussion, or customized supply proposal. A clear requirement at the beginning gives both sides a stronger basis for evaluation, purchasing, and long-term production planning.
For more Capillary Positive Controlinformation, please contact us. We will provide professional answers.